Immune Tolerance Network TrialShare
Names
More detailed information about this field from each metasource.
Immune Tolerance Network TrialShare
metasource: Fairsharing.org
version: FAIRsharing.org: TrialShare; Immune Tolerance Network TrialShare; DOI: https://doi.org/10.25504/FAIRsharing.xw1wj5; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:09 p.m.
TrialShare
metasource: Fairsharing.org
version: FAIRsharing.org: TrialShare; Immune Tolerance Network TrialShare; DOI: https://doi.org/10.25504/FAIRsharing.xw1wj5; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:09 p.m.
Names
More detailed information about this field from each metasource.
Immune Tolerance Network TrialShare
metasource: Fairsharing.orgversion: FAIRsharing.org: TrialShare; Immune Tolerance Network TrialShare; DOI: https://doi.org/10.25504/FAIRsharing.xw1wj5; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:09 p.m.
TrialShare
metasource: Fairsharing.orgversion: FAIRsharing.org: TrialShare; Immune Tolerance Network TrialShare; DOI: https://doi.org/10.25504/FAIRsharing.xw1wj5; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:09 p.m.
Names
More detailed information about this field from each metasource.
Immune Tolerance Network TrialShare
metasource: Fairsharing.orgversion: FAIRsharing.org: TrialShare; Immune Tolerance Network TrialShare; DOI: https://doi.org/10.25504/FAIRsharing.xw1wj5; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:09 p.m.
TrialShare
metasource: Fairsharing.orgversion: FAIRsharing.org: TrialShare; Immune Tolerance Network TrialShare; DOI: https://doi.org/10.25504/FAIRsharing.xw1wj5; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:09 p.m.
The immune tolerance data management and visualization portal for studies sponsored by the Immune Tolerance Network (ITN) and collaborating investigators. Data from published studies are accessible to any user; data from current in-progress studies are accessible to study investigators and collaborators. Includes links to published figures, tools for visualization and analysis of data, and ability to query study data by subject, group, or any other study parameter.
Description
More detailed information about this field from each metasource.
The immune tolerance data management and visualization portal for studies sponsored by the Immune Tolerance Network (ITN) and collaborating investigators. Data from published studies are accessible to any user; data from current in-progress studies are accessible to study investigators and collaborators. Includes links to published figures, tools for visualization and analysis of data, and ability to query study data by subject, group, or any other study parameter.
metasource: Fairsharing.orgversion: FAIRsharing.org: TrialShare; Immune Tolerance Network TrialShare; DOI: https://doi.org/10.25504/FAIRsharing.xw1wj5; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:09 p.m.
Webpage:
https://www.itntrialshare.org/Webpage
More detailed information about this field from each metasource.
https://www.itntrialshare.org/
metasource: Fairsharing.orgversion: FAIRsharing.org: TrialShare; Immune Tolerance Network TrialShare; DOI: https://doi.org/10.25504/FAIRsharing.xw1wj5; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:09 p.m.
Licence:
Name: ITN TrialShare Privacy PolicyLicence name
More detailed information about this field from each metasource.
ITN TrialShare Privacy Policy
metasource: Fairsharing.orgversion: FAIRsharing.org: TrialShare; Immune Tolerance Network TrialShare; DOI: https://doi.org/10.25504/FAIRsharing.xw1wj5; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:09 p.m.
Licence URL
More detailed information about this field from each metasource.
https://www.itntrialshare.org/tsstatic/privacy.html
metasource: Fairsharing.orgversion: FAIRsharing.org: TrialShare; Immune Tolerance Network TrialShare; DOI: https://doi.org/10.25504/FAIRsharing.xw1wj5; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:09 p.m.
Tags:
Tags
More detailed information about this field from each metasource.
antibody
metasource: Fairsharing.org
version: FAIRsharing.org: TrialShare; Immune Tolerance Network TrialShare; DOI: https://doi.org/10.25504/FAIRsharing.xw1wj5; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:09 p.m.
disease
metasource: Fairsharing.org
version: FAIRsharing.org: TrialShare; Immune Tolerance Network TrialShare; DOI: https://doi.org/10.25504/FAIRsharing.xw1wj5; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:09 p.m.
flow cytometry assay
metasource: Fairsharing.org
version: FAIRsharing.org: TrialShare; Immune Tolerance Network TrialShare; DOI: https://doi.org/10.25504/FAIRsharing.xw1wj5; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:09 p.m.
gene expression data
metasource: Fairsharing.org
version: FAIRsharing.org: TrialShare; Immune Tolerance Network TrialShare; DOI: https://doi.org/10.25504/FAIRsharing.xw1wj5; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:09 p.m.
immunity
metasource: Fairsharing.org
version: FAIRsharing.org: TrialShare; Immune Tolerance Network TrialShare; DOI: https://doi.org/10.25504/FAIRsharing.xw1wj5; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:09 p.m.
sequencing
metasource: Fairsharing.org
version: FAIRsharing.org: TrialShare; Immune Tolerance Network TrialShare; DOI: https://doi.org/10.25504/FAIRsharing.xw1wj5; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:09 p.m.
Tags
More detailed information about this field from each metasource.
antibody
metasource: Fairsharing.orgversion: FAIRsharing.org: TrialShare; Immune Tolerance Network TrialShare; DOI: https://doi.org/10.25504/FAIRsharing.xw1wj5; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:09 p.m.
disease
metasource: Fairsharing.orgversion: FAIRsharing.org: TrialShare; Immune Tolerance Network TrialShare; DOI: https://doi.org/10.25504/FAIRsharing.xw1wj5; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:09 p.m.
flow cytometry assay
metasource: Fairsharing.orgversion: FAIRsharing.org: TrialShare; Immune Tolerance Network TrialShare; DOI: https://doi.org/10.25504/FAIRsharing.xw1wj5; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:09 p.m.
gene expression data
metasource: Fairsharing.orgversion: FAIRsharing.org: TrialShare; Immune Tolerance Network TrialShare; DOI: https://doi.org/10.25504/FAIRsharing.xw1wj5; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:09 p.m.
immunity
metasource: Fairsharing.orgversion: FAIRsharing.org: TrialShare; Immune Tolerance Network TrialShare; DOI: https://doi.org/10.25504/FAIRsharing.xw1wj5; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:09 p.m.
sequencing
metasource: Fairsharing.orgversion: FAIRsharing.org: TrialShare; Immune Tolerance Network TrialShare; DOI: https://doi.org/10.25504/FAIRsharing.xw1wj5; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:09 p.m.
antibody disease flow cytometry assay gene expression immunity sequencing
Need help integrating and/or managing biomedical data?